Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events

BACKGROUND: Incorporating patient reporting of symptomatic adverse events (AEs) is important in evaluating safety and tolerability in cancer clinical trials. The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to assess the frequency,...

Descripción completa

Detalles Bibliográficos
Autores principales: Speck, Rebecca M., Lenderking, William R., Shaw, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104407/
https://www.ncbi.nlm.nih.gov/pubmed/30175317
http://dx.doi.org/10.1186/s41687-018-0063-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104407/
https://www.ncbi.nlm.nih.gov/pubmed/30175317
http://dx.doi.org/10.1186/s41687-018-0063-4

Ejemplares similares